Dao, T T <br/><br/>
Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.  [electronic resource] 

 -  Journal of hypertension  Jun 1998 
 - 779-92 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0263-6352 
<br/><br/><label>Standard No.: </label>10.1097/00004872-199816060-00009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adrenergic alpha-2 Receptor Antagonists<br/>Adrenergic alpha-Antagonists--pharmacology<br/>Adult<br/>Aged<br/>Blood Pressure--drug effects<br/>Catecholamines--blood<br/>Chromatography, High Pressure Liquid<br/>Chromogranin A<br/>Chromogranins--blood<br/>Female<br/>Humans<br/>Hypertension--genetics<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Phenotype<br/>Receptors, Adrenergic, alpha-2--genetics<br/>Renin--blood<br/>Risk Factors<br/>Stroke Volume--drug effects<br/>Vascular Resistance--drug effects<br/>Yohimbine--pharmacology